Skip to content

Drug interactions

Topiramate + Ubrogepant

Severity: Moderate

Topiramate and Ubrogepant: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Topiramate is a weak to moderate CYP3A4 inducer, which can lower ubrogepant concentrations and reduce its effectiveness for acute migraine. Ubrogepant labeling advises dose adjustment with CYP3A4 inducers.

What this interaction means in plain words

Topiramate and Ubrogepant can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Topiramate belongs to Central Nervous System; Ubrogepant belongs to Central Nervous System.

Evidence level: Moderate

Why it happens

Induction of CYP3A4 by topiramate increases ubrogepant metabolism.

What to do

Follow ubrogepant labeling for dosing with CYP3A4 inducers, using the higher initial dose where recommended. Monitor migraine response.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Topiramate and Ubrogepant, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Topiramate with Ubrogepant?

MediHelp rates the interaction as moderate. Topiramate and Ubrogepant can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Topiramate is a weak to moderate CYP3A4 inducer, which can lower ubrogepant concentrations and reduce its effectiveness for acute migraine. Ubrogepant labeling advises dose adjustment with CYP3A4 inducers.

How serious is the interaction between Topiramate and Ubrogepant?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Follow ubrogepant labeling for dosing with CYP3A4 inducers, using the higher initial dose where recommended. Monitor migraine response.

What other medicines interact with Topiramate?

MediHelp also lists interactions of Topiramate with, for example, Benzhydrocodone / acetaminophen, Buprenorphine long-acting, Buprenorphine subdermal implant. The full list is on the Topiramate page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in